Generate Biomedicines, Inc. (GENB)

15.16 -0.83 (-5.19%) USD  |  NASDAQ  |  Sep 25, 16:00
15.28 +0.12 (+0.79%) After-Hours: 19:59
More

Generate Biomedicines Research and Development Expense (Annual) : 211.63M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 211.63M
Date Value
December 31, 2024 160.31M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Twist Bioscience Corp. 80.28M
Intellia Therapeutics, Inc. 379.09M
Prime Medicine, Inc. 160.64M
Moderna, Inc. 2.917B
Beam Therapeutics, Inc. 409.62M